Leila Zarif

Title: Leila Zarif: Innovator in Cochleate Formulations

Introduction

Leila Zarif is a notable inventor based in Newark, NJ, who has made significant contributions to the field of pharmaceutical formulations. With a focus on nanotechnology, she has developed innovative methods for producing cochleates, which are lipid-based structures that have potential applications in drug delivery.

Latest Patents

Zarif holds a patent for "Nanocochleate formulations, process of preparation and method of." This patent describes a process for producing small-sized cochleates derived from liposomes suspended in an aqueous two-phase polymer solution. The method allows for the differential partitioning of polar molecules through phase separation. By treating the liposome-containing solution with positively charged molecules such as Ca²⁺ or Zn²⁺, a cochleate precipitate of less than one micron in size is formed. This innovative process can be utilized to create cochleates that contain pharmaceutical agents or biologically relevant molecules, which can be administered orally or through mucosal routes for effective treatment.

Career Highlights

Throughout her career, Leila Zarif has worked with prominent organizations, including Biodelivery Sciences, Inc. and the University of Medicine and Dentistry of New Jersey. Her work has focused on advancing the field of drug delivery systems, particularly through the development of cochleate formulations.

Collaborations

Zarif has collaborated with notable colleagues such as Tuo Jin and Raphael J Mannino, contributing to the advancement of her research and the successful development of her patented technologies.

Conclusion

Leila Zarif's innovative work in cochleate formulations exemplifies her commitment to enhancing drug delivery methods. Her contributions have the potential to significantly impact the pharmaceutical industry and improve treatment options for patients.